IP Library › Granted Patent US 10,350,334
Granted Patent B2
US 10,350,334 · App. 15/659,960 · Granted Jul 16, 2019

Catheter locking solution having antimicrobial and anticoagulation properties

Inventors: John J. Kelley, III (Glen Rock, NJ); Thelma I. Valdes (Wayne, NJ)
Assignee: Becton, Dickinson and Company
A61L33/0041A61K9/0019A61K31/167A61K31/245A61K31/445A61K31/47A61L29/06A61L29/14A61L29/16A61L33/04A61L33/068A61K47/36A61K2300/00A61L2300/402A61L2300/404A61L2300/42A61M25/00A61M2025/0019A61M2025/0056
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,350,334
App. No.
15/659,960
Granted
Jul 16, 2019
Kind
B2
Abstract

The present invention includes a catheter locking solution having both antimicrobial and anticoagulant properties including a local anesthetic and a viscosifying agent. The local anesthetic of the present invention may be an amino amide; an amino ester; an aminoacylanilide; an aminoalkyl benzoate; an amino carbonate; an N-phenylamidine compound; an N-aminoalkyl amid; an aminoketone, or combinations and mixtures thereof. In a particular embodiment of the present invention, the local anesthetic is tetracaine or dibucaine.

Claims (18)

1. A catheter locking solution comprising:

a local anesthetic comprising at least one of dibucaine and tetracaine having anticoagulant and antimicrobial activity to reduce microbial growth and coagulation in an implanted catheter.

2. The catheter locking solution of claim 1 , wherein the local anesthetic comprises one or more of an amino amide, an amino ester, an aminoacylanilide, an aminoalkyl benzoate, an amino carbonate, an N-phenylamidine compound, an N-aminoalkyl amid, an aminoketone, and combinations thereof.

3. The catheter locking solution of claim 1 , wherein the local anesthetic further comprises one or more of bupivacaine, ropivacaine, etidocaine, lidocaine, prilocaine, procaine, novocaine, choloroprocaine, propoxycaine, chlorocaine, mepivacaine, xylocaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine, popoxycaine, proparacaine, articaine, carticaine, levobupivacaine, piperocaine, trimecaine, hexylcaine, benoxinate, butucaine, diperodon, phenacaine, falicaine, dyclonine, pramoxine, dimethisoquien, and combinations thereof.

4. The catheter locking solution of claim 1 , wherein the local anesthetic is present in an amount of 0.05 mg/mL-100 mg/mL.

5. The catheter locking solution of claim 1 , wherein the local anesthetic is present in an amount of 0.24 mg/mL-28.2 mg/mL.

6. The catheter locking solution of claim 1 , further comprising an additional antimicrobial agent.

7. A pre-filled syringe comprising a syringe containing a locking solution, said locking solution comprising:

a local anesthetic comprising at least one of dibucaine and tetracaine having anticoagulant and antimicrobial activity to reduce microbial growth and coagulation in an implanted catheter.

8. The pre-filled syringe of claim 7 , wherein the local anesthetic comprises one or more of an amino amide, an amino ester, an aminoacylanilide, an aminoalkyl benzoate, an amino carbonate, an N-phenylamidine compound, an N-aminoalkyl amid, an aminoketone, and combinations thereof.

9. The pre-filled syringe of claim 7 , wherein the local anesthetic further comprises one or more of bupivacaine, ropivacaine, etidocaine, lidocaine, prilocaine, procaine, novocaine, choloroprocaine, propoxycaine, chlorocaine, mepivacaine, xylocaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine, popoxycaine, proparacaine, articaine, carticaine, levobupivacaine, piperocaine, trimecaine, hexylcaine, benoxinate, butucaine, diperodon, phenacaine, falicaine, dyclonine, pramoxine, dimethisoquien, and combinations thereof.

10. The pre-filled syringe of claim 7 , wherein the local anesthetic is present in an amount of 0.05 mg/mL-100 mg/mL.

11. The pre-filled syringe of claim 7 , wherein the local anesthetic is present in an amount of 0.24 mg/mL-28.2 mg/mL.

12. The pre-filled syringe of claim 7 , further comprising an additional antimicrobial agent.

13. A catheter comprising a tube defining a lumen therethrough, wherein at least a portion of the lumen is infused with a catheter locking solution, said catheter locking solution comprising:

a local anesthetic comprising at least one of dibucaine and tetracaine having anticoagulant and antimicrobial activity to reduce microbial growth and coagulation in the catheter.

14. The catheter of claim 13 , wherein the local anesthetic comprises one or more of an amino amide, an amino ester, an aminoacylanilide, an aminoalkyl benzoate, an amino carbonate, an N-phenylamidine compound, an N-aminoalkyl amid, an aminoketone, and combinations thereof.

15. The catheter of claim 13 , wherein the local anesthetic further comprises one or more of bupivacaine, ropivacaine, etidocaine, lidocaine, prilocaine, procaine, novocaine, choloroprocaine, propoxycaine, chlorocaine, mepivacaine, xylocaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine, popoxycaine, proparacaine, articaine, carticaine, levobupivacaine, piperocaine, trimecaine, hexylcaine, benoxinate, butucaine, diperodon, phenacaine, falicaine, dyclonine, pramoxine, dimethisoquien, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: KELLEY, JOHN J., III; VALDES, THELMA I.
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 043103/0245 →
Continuity (4)
Continuation 14972953 · Dec 17, 2015
Continuation 12797336 · Jun 9, 2010
Provisional Application 61186173 · Jun 11, 2009
Related Publication 20170319757A1 · Nov 9, 2017
Cited By (1)
US 12,285,573